GlassScriptPhysician profile
Katherine A Lambert
NPI 1093855819
$4,776.18
in general payments reported to CMS, 2019-2025
56 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $456 · 2022: $864 · 2023: $892 · 2024: $1,009 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,456.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $582.95 | 2021-2025 | |
| Janssen Biotech, INC. | $396.65 | 2021-2025 | Rybrevant, Carvykti, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $220.33 | 2021-2025 | Calquence, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $201.89 | 2022-2025 | Opdivo, Krazati, Opdualag |
| Merck Sharp & Dohme LLC | $192.85 | 2021-2025 | Keytruda, Lynparza |
| Takeda Pharmaceuticals U.S.A., INC. | $181.51 | 2022-2025 | Iclusig, Alunbrig |
| Lilly USA, LLC | $167.98 | 2021-2025 | Verzenio, Jaypirca |
| Genentech USA, INC. | $158.85 | 2022-2025 | Venclexta, Polivy, Lunsumio |
| Pfizer INC. | $153.76 | 2022-2025 | |
| Gilead Sciences, INC. | $150.32 | 2022-2025 | Trodelvy |
| Seagen INC. | $140.35 | 2021-2022 | |
| Glaxosmithkline, LLC. | $134.58 | 2022-2025 | Ojjaara, Jemperli, Zejula |
| Amgen INC. | $134.48 | 2021-2023 | Lumakras |
| Eisai INC. | $123.25 | 2022-2025 | |
| Pharmaessentia USA Corporation | $120.17 | 2022-2025 | Besremi |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $97.98 | 2022-2025 | Enhertu, Datroway |
| Incyte Corporation | $97.46 | 2023-2025 | Monjuvi, Jakafi, Pemazyre |
| Regeneron Healthcare Solutions, INC. | $95.42 | 2022-2025 | Libtayo |
| Organon LLC | $69.02 | 2022-2024 | Ontruzant |
| Abbvie INC. | $67.46 | 2021-2025 | |
| Beigene USA, INC. | $63.25 | 2024 | Brukinsa, Tevimbra |
| Astellas Pharma US INC | $63.10 | 2023-2024 | Vyloy, Padcev, Xospata |
| Aveo Pharmaceuticals, INC. | $61.68 | 2021-2023 | Fotivda |
| Exelixis INC. | $60.67 | 2021-2025 | Cabometyx |
| Bayer Healthcare Pharmaceuticals INC. | $57.04 | 2025 | |
| Morphosys, US INC. | $54.02 | 2021-2023 | Monjuvi |
| Deciphera Pharmaceuticals INC. | $52.02 | 2021-2025 | Qinlock, Romvimza |
| Amneal Pharmaceuticals LLC | $50.44 | 2023-2025 | Alymsys, Avastin |
| Pharmaand Gmbh | $50.33 | 2025 | Rubraca |
| Tolmar, INC. | $50.33 | 2025 | Eligard, Rubraca |
| Taiho Oncology, INC. | $50.12 | 2023-2025 | |
| Celgene Corporation | $47.37 | 2023-2025 | Reblozyl, Opdualag |
| Stemline Therapeutics INC. | $43.66 | 2025 | Orserdu |
| Sobi, INC | $43.48 | 2022-2024 | |
| Genzyme Corporation | $40.44 | 2025 | |
| Avyxa Pharma, LLC | $34.68 | 2025 | |
| Heron Therapeutics, INC. | $34.55 | 2021 | |
| Genmab U.S., INC. | $33.06 | 2024 | Epkinly |
| Syndax Pharmaceuticals, INC. | $31.97 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.30 | 2022 | |
| Geron Corporation | $28.56 | 2025 | Rytelo |
| Adaptive Biotechnologies Corporation | $27.57 | 2025 | Clonoseq |
| Karyopharm Therapeutics INC. | $26.79 | 2022 | |
| Pharmacosmos Therapeutics INC. | $26.68 | 2023 | Monoferric |
| Rigel Pharmaceuticals, INC. | $25.64 | 2024 | Rezlidhia, Tavalisse |
| Alexion Pharmaceuticals, INC. | $22.83 | 2021 | |
| Myovant Sciences INC. | $22.48 | 2022 | |
| Sumitomo Pharma America, INC. | $21.40 | 2024 | Orgovyx |
| Kyowa Kirin, INC. | $20.91 | 2022 | |
| Beone Medicines USA, INC. | $20.05 | 2025 | Brukinsa |
| Global Blood Therapeutics, INC. | $19.82 | 2022 | |
| Kite Pharma, INC. | $16.22 | 2023 | Yescarta |
| Puma Biotechnology, INC. | $15.97 | 2023 | Nerlynx |
| Accord Healthcare, INC. | $15.15 | 2025 | |
| Medtronic, INC. | $14.20 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.